Karen A. Autio, Atish Dipankar Choudhury, Travis A. Gerke, Andrea Arfe, Heather H. Cheng, Rana R. McKay, Emmanuel S. Antonarakis, Vivek Narayan, Michael A. Zielinski, Alicia K. Morgans. "TALENT: A randomized phase 2 study of talazoparib with or without enzalutamide in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) alterations after progression on abiraterone acetate.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5145